cis-tert-Butyl hexahydropyrrolo[3,4-b][1,4]oxazine-6(2H)-carboxylate

95%

Reagent Code: #150783
fingerprint
CAS Number 138027-02-8

science Other reagents with same CAS 138027-02-8

blur_circular Chemical Specifications

scatter_plot Molecular Information
Weight 228.29 g/mol
Formula C₁₁H₂₀N₂O₃
badge Registry Numbers
MDL Number MFCD12198674
thermostat Physical Properties
Boiling Point 324.9±32.0 °C(Predicted)
inventory_2 Storage & Handling
Density 1.108±0.06 g/cm3(Predicted)
Storage Room temperature

description Product Description

Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of protease inhibitors and other biologically active molecules. Its rigid, stereochemically defined structure makes it valuable in medicinal chemistry for constructing complex ring systems with high enantioselectivity. Commonly employed in asymmetric synthesis to introduce specific stereochemistry in drug candidates, especially those targeting central nervous system disorders and viral infections. Also utilized in the preparation of constrained peptidomimetics to enhance metabolic stability and receptor selectivity.

shopping_cart Available Sizes & Pricing

Size Availability Unit Price Quantity
inventory 100mg
10-20 days ฿9,790.00
inventory 250mg
10-20 days ฿15,660.00
inventory 1g
10-20 days ฿39,100.00

Cart

No products

Subtotal: 0.00
Total 0.00 THB
cis-tert-Butyl hexahydropyrrolo[3,4-b][1,4]oxazine-6(2H)-carboxylate
No image available

Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of protease inhibitors and other biologically active molecules. Its rigid, stereochemically defined structure makes it valuable in medicinal chemistry for constructing complex ring systems with high enantioselectivity. Commonly employed in asymmetric synthesis to introduce specific stereochemistry in drug candidates, especially those targeting central nervous system disorders and viral infections.

Used as a key chiral intermediate in the synthesis of pharmaceutical agents, particularly in the development of protease inhibitors and other biologically active molecules. Its rigid, stereochemically defined structure makes it valuable in medicinal chemistry for constructing complex ring systems with high enantioselectivity. Commonly employed in asymmetric synthesis to introduce specific stereochemistry in drug candidates, especially those targeting central nervous system disorders and viral infections. Also utilized in the preparation of constrained peptidomimetics to enhance metabolic stability and receptor selectivity.

Mechanism -
Appearance -
Longevity -
Strength -
Storage -
Shelf Life -
Allergen(s) -
Dosage (Range) -
Dosage (Per Day) -
Mix Method -
Heat Resistance -
Stable in pH range -
Solubility -
Product Types -
INCI -

Purchase History for

Loading purchase history...